Ovid Therapeutics Inc.
USD2.41
+0.10 (+4.56%)
CEO
Margaret Alexander
IPO Date
2017-05-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.31
Prev. Close
$2.31
Day Low
$2.29
Day High
$2.44
52W Low
$0.47
52W High
$3.10
Market Cap
$0.32B
Volume
1.78M
| 0 |
| $0.00 |
| 8 Jul 2026 | Carter Charles Ross | Chief Financial Officer | Disposed | 200,000 | $1.14 |
| 8 Jul 2026 | Carter Charles Ross | Chief Financial Officer | Disposed | 206,250 | $1.65 |
| 17 Jun 2026 | Greka Anna | director | A-Award | Acquired | 130,000 | $2.26 |
| 17 Jun 2026 | Greka Anna | — | Disposed | 0 | $0.00 |
| 9 Apr 2026 | PAPADOPOULOS STELIOS | director | A-Award | Acquired | 17,578 | $2.56 |
| 9 Apr 2026 | Friedman Bart | director | A-Award | Acquired | 8,789 | $2.56 |
| 9 Apr 2026 | Fitzgerald Kevin Joseph | director | A-Award | Acquired | 17,578 | $2.56 |
| 25 Mar 2026 | LEVIN JEREMY M | director, officer: Executive Chairman | M-Exempt | Acquired | 47,333 | $1.40 |